Table 4.
DVT-LE Extent of DVT, Treatment, and Outcomes
| Patient # |
Extent of DVT (Thrombosed segments) | Marder scores pre/post- Tx |
Doses of tPA mg)* |
Ancillary Tx | Patency restored? |
|---|---|---|---|---|---|
| 1 | L::SFV, PV, PerV, PTV | 26 / 6 | 7.5 / 10 / 4 | None | Yes |
| 2 | L: PV, PerV, PTV | 16 / 7 | 8 / 8 / 4 | TLA (8mm):PV, Per –PTV tk | No |
| 3 | R: EIV, CFV, SFV, PFV, PV(2) PerV, PTV | 36 / 9 | 10 / 10 / 6 | TLA (6mm): PV, PerV | Yes |
| 4 | L: SFV, PV, PerV, PTV | 26 / 4 | 10 / 6 | None | Yes |
| 5 | R: SFV, PV, PerV, PTV | 26 / 4 | 8 / 10 | None | Yes |
| 6 | L: SFV, PV, PerV, PTV | 26 / 6 | 8 / 8 / 4 | None | Yes |
| 7 | R: PV(2), PerV, PTV | 16 / 4 | 8 | None | Yes |
| 8 | L: EIV, CFV, SFV, PFV, PV, PerV, PTV | 36 / 9 | 10 / 10 / 10 / 8 | TLA (8mm): SFV-PV | Yes |
| 9 | L: CIV, EIV, CFV, PFV, SFV | 20 / 4 | 8 / 5 / 4 | TLA (10mm): L CIV. | Yes |
| 10 | L: PV, PerV, PTV | 16 / 4 | 7 / 7 / 4 | TLA (8mm): PV | Yes |
| 11 | R: SFV, PV, PerV, PTV, LSV | 26 / 4 | 8 / 6 | 2mg tPA into LSV clot | Yes |
| 12 | L: SFV, PV, PerV, PTV | 26 / 4 | 8 / 6 | None | Yes |
| 13 | L: SFV, PV, PerV, PTV. | 26 / 6 | 6 / 8 | None | Yes |
| 14 | R: SFV, PV | 14 / 3 | 5 / 4 | None | Yes |
| 15 | R: SFV, PV(2), PerV, PTV | 26 / 5 | 8 / 10 / 6 | TLA (8mm): both dup. PV | Yes |
| 16 | R: SFV, PV, PerV, PTV | 26 / 7 | 7 / 10 | TLA (8mm) : PV | Yes |
| 17 | L: SFV; PV, PerV, PTV, ATV, plantar v | 30 / 7.5 | 10 / 10 / 6 | None | Yes |
| 18 | L: SFV, PV, PerV, PTV, ATV, plantar v | 30 / 7.5 | 10 / 10 / 10 | TLA: 8 mm PopV/ 6mm PerV | Yes |
| 19 | R: PV; PerV, PTV | 16 / 4 | 8 / 8 / 5 | None | Yes |
| 20 | L: IVC, CIV to PerV, PTV, IIV, PFV; R: CIV | 40+/ 10 | 10 / 10 / 8 | TLA (16mm):IVC/8mm: R CIV | Yes |
| 21 | R: SFV, PV, PerV, ATV, PTV, +plantar v | 30 / 7.5 | 10 / 8 / 8 | None | Yes |
| 22 | R: SFV; PV, PTV | 20 / 5 | 8 / 6 | TLA(8mm):SFV;(6mm}: PV | Yes |
| 23 | L: CIV, IIV, EIV | 6 / 1.5 | 6 / 4 | 12mm Stent: CIV | Yes |
| 24 | R: EIV, CFV, PFV.SFV | 20 / 5 | 10 / 8 | None | Yes |
| 25 | L: CIV, IIV, EIV, CFV | 10 / 1.5 | 6 / 6 / 4 | 14mm Stents (2): CIV | Yes |
| 26 | L: CIV, EIV, IIV, CFV, PFV, SFV, PV | 24 / 6 | 8 / 10 / 5 / 2 | TLA (8mm +10mm): L CIV | Yes |
| 27 | L: SFV, PV(2); Per V, PTV | 26 / 4 | 6 / 6 / 6 | TLA (8mm): PV; (5mm): PerV | Yes |
| 28 | L: CIV, EIV, CFV | 10 / 1 | 6 / 6 / 4 | TLA (10mm);12mm CIV stent | Yes |
| 29 | L: EIV, CFV, PFV, SFV, PV, PerV, PTV | 36 / 11 | 10 / 8 / 4 | TLA (6mm) PerV | Yes |
| 30 | L: CIV, IIV. EIV, CFV, proximal SFV | 20 / 2.5 | 8 / 6 / 6 / 6 | TLA (10 mm): CIV & EIV | Yes |
Legend:
Column 1: All patients were protocol patients.
Column 2 & 5: (vein segments): R= right; L= left; SFV= femoral vein of thigh (aka superficial femoral vein); PV(2) = popliteal vein (duplicated); PFV= profunda femoral vein; PerV=peroneal vein; PTV=posterior tibial vein; ATV= anterior tibial vein; CIV = common iliac vein; EIV = external iliac vein; IIV = internal iliac vein; CFV= common femoral vein; LSV=lesser saphenous vein.
Column 4: Patient receives only 1 tPA dose or treatment per day; Hence, # of tPA doses equals # of days of thrombolytic therapy.
Column 5: tk = trunk; TLA = transluminal angioplasty or balloon dilatation (inflated balloon diameter): followed by site of TLA